|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of RAPT Therapeutics (NASDAQ: RAPT) through any online brokerage.
The latest price target for RAPT Therapeutics (NASDAQ: RAPT) was reported by Cantor Fitzgerald on June 14, 2021. The analyst firm set a price target for 71.00 expecting RAPT to rise to within 12 months (a possible 77.41% upside). 6 analyst firms have reported ratings in the last year.
The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $40.02 last updated Mon Jun 14 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for RAPT Therapeutics.
There is no upcoming split for RAPT Therapeutics.
RAPT Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.